Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

632 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: Long-Term Clinical Outcomes.
Tan VS, Correa RJM, Nguyen TK, Louie AV, Malthaner RA, Fortin D, Rodrigues GB, Yaremko BP, Laba JM, Kwan K, Gaede S, Lee T, Ward AD, Warner A, Inculet RI, Palma DA. Tan VS, et al. Among authors: fortin d. Int J Radiat Oncol Biol Phys. 2025 Jan 1;121(1):39-44. doi: 10.1016/j.ijrobp.2024.07.2332. Epub 2024 Oct 1. Int J Radiat Oncol Biol Phys. 2025. PMID: 39362312 Free article. Clinical Trial.
Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC).
Palma DA, Nguyen TK, Kwan K, Gaede S, Landis M, Malthaner R, Fortin D, Louie AV, Frechette E, Rodrigues GB, Yaremko B, Yu E, Dar AR, Lee TY, Gratton A, Warner A, Ward A, Inculet R. Palma DA, et al. Among authors: fortin d. Radiat Oncol. 2017 Jan 27;12(1):30. doi: 10.1186/s13014-017-0770-7. Radiat Oncol. 2017. PMID: 28129789 Free PMC article. Clinical Trial.
Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid 18 F-fluorodeoxyglucose-positron emission tomography and CT perfusion study.
Yang DM, Palma D, Louie A, Malthaner R, Fortin D, Rodrigues G, Yaremko B, Laba J, Gaede S, Warner A, Inculet R, Lee TY. Yang DM, et al. Among authors: fortin d. J Med Imaging Radiat Oncol. 2019 Feb;63(1):94-101. doi: 10.1111/1754-9485.12807. Epub 2018 Oct 3. J Med Imaging Radiat Oncol. 2019. PMID: 30281918 Clinical Trial.
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.
Palma DA, Nguyen TK, Louie AV, Malthaner R, Fortin D, Rodrigues GB, Yaremko B, Laba J, Kwan K, Gaede S, Lee T, Ward A, Warner A, Inculet R. Palma DA, et al. Among authors: fortin d. JAMA Oncol. 2019 May 1;5(5):681-688. doi: 10.1001/jamaoncol.2018.6993. JAMA Oncol. 2019. PMID: 30789648 Free PMC article. Clinical Trial.
Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory clinical study.
Yang DM, Palma DA, Kwan K, Louie AV, Malthaner R, Fortin D, Rodrigues GB, Yaremko BP, Laba J, Gaede S, Warner A, Inculet R, Lee TY. Yang DM, et al. Among authors: fortin d. Radiat Oncol. 2021 Jan 13;16(1):11. doi: 10.1186/s13014-021-01747-z. Radiat Oncol. 2021. PMID: 33441162 Free PMC article.
The quality of life in neoadjuvant versus adjuvant therapy of esophageal cancer treatment trial (QUINTETT): Randomized parallel clinical superiority trial.
Malthaner RA, Yu E, Sanatani M, Lewis D, Warner A, Dar AR, Yaremko BP, Bierer J, Palma DA, Fortin D, Inculet RI, Fréchette E, Raphael J, Gaede S, Kuruvilla S, Younus J, Vincent MD, Rodrigues GB. Malthaner RA, et al. Among authors: fortin d. Thorac Cancer. 2022 Jul;13(13):1898-1915. doi: 10.1111/1759-7714.14433. Epub 2022 May 24. Thorac Cancer. 2022. PMID: 35611396 Free PMC article. Clinical Trial.
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial.
Yu E, Allan AL, Sanatani M, Lewis D, Warner A, Dar AR, Yaremko BP, Lowes LE, Palma DA, Raphael J, Vincent MD, Rodrigues GB, Fortin D, Inculet RI, Frechette E, Bierer J, Law J, Younus J, Malthaner RA. Yu E, et al. Among authors: fortin d. BMC Cancer. 2022 Jul 8;22(1):746. doi: 10.1186/s12885-022-09846-0. BMC Cancer. 2022. PMID: 35804307 Free PMC article. Clinical Trial.
What is the predictive value of RECIST criteria following stereotactic lung radiation?
Gulstene S, Lang P, Melody Qu X, Laba JM, Yaremko BP, Rodrigues GB, Yu E, Qiabi M, Nayak R, Malthaner RA, Fortin D, Warner A, Inculet RI, Palma DA. Gulstene S, et al. Among authors: fortin d. Radiother Oncol. 2024 Jan;190:109976. doi: 10.1016/j.radonc.2023.109976. Epub 2023 Oct 31. Radiother Oncol. 2024. PMID: 37918636 Review.
632 results